Author:
Kim Harrison,Buchsbaum Donald J.,Zinn Kurt R.
Funder
Susan G. Komen for the Cure
National Institutes of Health
UAB radiology
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology
Reference39 articles.
1. Ichikawa K, Liu W, Zhao L et al (2001) Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7:954–960
2. Forero-Torres A, Shah J, Wood T et al (2010) Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5). Cancer Biother Radiopharm 25:13–19
3. Buchsbaum DJ, Zhou T, Grizzle WE et al (2003) Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Clin Cancer Res 9:3731–3741
4. Oliver PG, LoBuglio AF, Zhou T et al (2012) Effect of anti-DR5 and chemotherapy on basal-like breast cancer. Breast Cancer Res Treat 133:417–426
5. Estes JM, Oliver PG, Straughn JM Jr et al (2007) Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model. Gynecol Oncol 105:291–298
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献